FY2020 Requests for Applications

These Funding Opportunity Announcements (FOA) are associated with the Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, these FOAs target the following area designated as scientific priority by the Blue Ribbon Panel (BRP):
Recommendation B. Create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers.

  • RFA-CA-19-044, Advancing Cancer Immunotherapy by Mitigating Immune-Related Adverse Events (irAE) (U01 Clinical Trial Not Allowed)
  • NOT-CA-19-047, Notice of Intent to Publish: Funding Opportunity Announcement for Human Immune-Representing Oncology Models for Immuno-Oncology Research (R33 Clinical Trial Optional)

The FY2020 requests for applications have been closed. The detailed information of awardees is available at IOTN awardees.